Shares of Integer Holdings Corporation (NYSE:ITGR - Get Free Report) have received an average recommendation of "Hold" from the fourteen ratings firms that are currently covering the company, Marketbeat reports. Thirteen equities research analysts have rated the stock with a hold recommendation and one has assigned a buy recommendation to the company. The average twelve-month target price among brokerages that have issued ratings on the stock in the last year is $109.8571.
Several analysts recently commented on ITGR shares. HC Wainwright reaffirmed a "buy" rating on shares of Integer in a report on Friday, July 24th. Benchmark downgraded Integer from a "buy" rating to a "hold" rating in a report on Thursday, August 13th. Weiss Ratings restated a "hold (c)" rating on shares of Integer in a research report on Thursday, June 18th. Zacks Research raised shares of Integer from a "strong sell" rating to a "hold" rating in a research note on Monday, July 20th. Finally, KeyCorp lowered shares of Integer from an "overweight" rating to a "sector weight" rating in a report on Monday, August 3rd.
Check Out Our Latest Analysis on ITGR
Integer Trading Up 0.0%
NYSE ITGR opened at $125.11 on Wednesday. The company has a market capitalization of $4.25 billion, a PE ratio of 34.18, a P/E/G ratio of 2.98 and a beta of 0.61. The company has a fifty day moving average of $102.09 and a 200 day moving average of $92.33. Integer has a 1 year low of $62.00 and a 1 year high of $126.14. The company has a debt-to-equity ratio of 0.75, a current ratio of 3.73 and a quick ratio of 2.41.
Integer (NYSE:ITGR - Get Free Report) last announced its quarterly earnings results on Monday, August 3rd. The medical equipment provider reported $1.60 earnings per share for the quarter, topping the consensus estimate of $1.38 by $0.22. The company had revenue of $464.11 million for the quarter, compared to the consensus estimate of $451.07 million. Integer had a return on equity of 12.79% and a net margin of 6.97%.The firm's revenue for the quarter was down 2.6% compared to the same quarter last year. During the same period last year, the firm earned $1.55 EPS. Research analysts forecast that Integer will post 6.08 earnings per share for the current year.
Institutional Trading of Integer
Several hedge funds and other institutional investors have recently added to or reduced their stakes in ITGR. Barrow Hanley Mewhinney & Strauss LLC acquired a new position in shares of Integer in the second quarter worth about $29,000. EverSource Wealth Advisors LLC grew its position in shares of Integer by 48.1% during the 1st quarter. EverSource Wealth Advisors LLC now owns 360 shares of the medical equipment provider's stock valued at $32,000 after acquiring an additional 117 shares during the period. Salomon & Ludwin LLC grew its position in shares of Integer by 46.8% during the 4th quarter. Salomon & Ludwin LLC now owns 370 shares of the medical equipment provider's stock valued at $29,000 after acquiring an additional 118 shares during the period. Harbor Investment Advisory LLC purchased a new position in shares of Integer in the 2nd quarter valued at about $42,000. Finally, TD Private Client Wealth LLC increased its stake in shares of Integer by 1,037.5% in the 4th quarter. TD Private Client Wealth LLC now owns 455 shares of the medical equipment provider's stock valued at $36,000 after purchasing an additional 415 shares in the last quarter. Institutional investors and hedge funds own 99.29% of the company's stock.
About Integer
(
Get Free Report)
Integer Holdings Corporation NYSE: ITGR is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.
Integer's product portfolio is organized into two core segments: Advanced Delivery and MedTech.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Integer, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Integer wasn't on the list.
While Integer currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.